Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jared Silver

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 10, 2022
Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptionsJohn Oppenheimer, Flavia C L Hoyte, Wanda Phipatanakul, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 1, 2020
Endophenotyping Oxaliplatin Hypersensitivity: Personalizing Desensitization to the Atypical PlatinJared Silver, Marlene Garcia-Neuer, Donna-Marie Lynch, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 6, 2021
Factors leading to discontinuation of biologic therapy in patients with severe asthmaJared Silver, Michael Bogart, Nestor A Molfino, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 5, 2026
Mepolizumab Demonstrates Quantifiable Reduction in Corticosteroid-Related Adverse Effects in Severe AsthmaNjira L Lugogo, Jared Silver, William W Busse, et al.
Clinical and Translational Allergy|January 11, 2025
Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approachOliver Pfaar, Anju T Peters, Camille Taillé, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 26, 2021
Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbiditiesThomas Casale, Nestor A Molfino, Jared Silver, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 14, 2021
A real-world study of inhaled corticosteroid use in patients with severe eosinophilic asthma treated with mepolizumabJonathan Corren, Jared Silver, Nestor A Molfino, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 20, 2026
Mepolizumab reduces healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps: a linked EMR and claims-based pre-post studyAnna Swenson, Waseem Ahmed, Jared Silver, et al.
The Journal of Allergy and Clinical Immunology. Global|July 14, 2025
Burden of hypereosinophilic syndromes in the United States: Patients' perspectiveJared Silver, Anna Kovalszki, Mary Jo Strobel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 16, 2024
Real-world mepolizumab treatment in eosinophilic granulomatosis with polyangiitis reduces disease burden in the United StatesSameer K Mathur, Jared Silver, Sean D MacKnight, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 10, 2022
Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptionsJohn Oppenheimer, Flavia C L Hoyte, Wanda Phipatanakul, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 1, 2020
Endophenotyping Oxaliplatin Hypersensitivity: Personalizing Desensitization to the Atypical PlatinJared Silver, Marlene Garcia-Neuer, Donna-Marie Lynch, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 6, 2021
Factors leading to discontinuation of biologic therapy in patients with severe asthmaJared Silver, Michael Bogart, Nestor A Molfino, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 5, 2026
Mepolizumab Demonstrates Quantifiable Reduction in Corticosteroid-Related Adverse Effects in Severe AsthmaNjira L Lugogo, Jared Silver, William W Busse, et al.
Clinical and Translational Allergy|January 11, 2025
Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approachOliver Pfaar, Anju T Peters, Camille Taillé, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 26, 2021
Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbiditiesThomas Casale, Nestor A Molfino, Jared Silver, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 14, 2021
A real-world study of inhaled corticosteroid use in patients with severe eosinophilic asthma treated with mepolizumabJonathan Corren, Jared Silver, Nestor A Molfino, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 20, 2026
Mepolizumab reduces healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps: a linked EMR and claims-based pre-post studyAnna Swenson, Waseem Ahmed, Jared Silver, et al.
The Journal of Allergy and Clinical Immunology. Global|July 14, 2025
Burden of hypereosinophilic syndromes in the United States: Patients' perspectiveJared Silver, Anna Kovalszki, Mary Jo Strobel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 16, 2024
Real-world mepolizumab treatment in eosinophilic granulomatosis with polyangiitis reduces disease burden in the United StatesSameer K Mathur, Jared Silver, Sean D MacKnight, et al.
Pageof 4